O	0	3	Brn	Brn	JJ	B-NP
O	3	4	-	-	HYPH	I-NP
O	4	6	3a	3a	NN	I-NP
O	6	7	,	,	,	O
O	8	9	a	a	DT	B-NP
B-Cell	10	18	neuronal	neuronal	JJ	I-NP
O	19	32	transcription	transcription	NN	I-NP
O	33	39	factor	factor	NN	I-NP
O	40	42	of	of	IN	B-PP
O	43	46	the	the	DT	B-NP
O	47	50	POU	POU	NN	I-NP
O	51	55	gene	gene	NN	I-NP
O	56	62	family	family	NN	I-NP
O	62	63	:	:	:	O
O	64	75	indications	indication	NNS	B-NP
O	76	79	for	for	IN	B-PP
O	80	83	its	its	PRP$	B-NP
O	84	95	involvement	involvement	NN	I-NP
O	96	98	in	in	IN	B-PP
B-Cancer	99	105	cancer	cancer	NN	B-NP
O	106	109	and	and	CC	I-NP
O	110	122	angiogenesis	angiogenesis	NN	I-NP
O	122	123	.	.	.	O

O	124	127	Brn	Brn	JJ	B-NP
O	127	128	-	-	HYPH	I-NP
O	128	130	3a	3a	NN	I-NP
O	130	131	,	,	,	O
O	132	133	a	a	DT	B-NP
O	134	140	member	member	NN	I-NP
O	141	143	of	of	IN	B-PP
O	144	147	the	the	DT	B-NP
O	148	151	POU	POU	NN	I-NP
O	152	156	gene	gene	NN	I-NP
O	157	163	family	family	NN	I-NP
O	164	165	(	(	(	O
O	165	167	so	so	RB	O
O	167	168	-	-	HYPH	O
O	168	174	called	call	VBN	B-VP
O	175	182	because	because	RB	B-PP
O	183	185	of	of	IN	I-PP
O	186	189	the	the	DT	B-NP
O	190	200	similarity	similarity	NN	I-NP
O	201	205	with	with	IN	B-PP
O	206	209	the	the	DT	B-NP
O	210	215	group	group	NN	I-NP
O	216	218	of	of	IN	B-PP
O	219	232	transcription	transcription	NN	B-NP
O	233	240	factors	factor	NNS	I-NP
O	241	244	Pit	Pit	NN	B-NP
O	244	245	,	,	,	O
O	246	249	Oct	Oct	NN	B-NP
O	249	250	,	,	,	O
O	251	254	and	and	CC	O
O	255	258	Unc	Unc	NN	B-NP
O	258	259	)	)	)	O
O	259	260	,	,	,	O
O	261	264	was	be	VBD	B-VP
O	265	270	found	find	VBN	I-VP
O	271	273	in	in	IN	B-PP
B-Cell	274	282	neuronal	neuronal	JJ	B-NP
I-Cell	283	288	cells	cell	NNS	I-NP
O	289	296	engaged	engage	VBN	B-VP
O	297	299	in	in	IN	B-PP
O	300	303	the	the	DT	B-NP
O	304	317	transcription	transcription	NN	I-NP
O	318	326	activity	activity	NN	I-NP
O	327	329	of	of	IN	B-PP
O	330	333	the	the	DT	B-NP
O	334	336	p1	p1	NN	I-NP
O	337	340	and	and	CC	I-NP
O	341	343	p2	p2	NN	I-NP
O	344	353	promoters	promoter	NNS	I-NP
O	354	356	of	of	IN	B-PP
O	357	360	the	the	DT	B-NP
O	361	365	most	most	RBS	I-NP
O	366	374	powerful	powerful	JJ	I-NP
O	375	388	antiapoptotic	antiapoptotic	JJ	I-NP
O	389	393	gene	gene	NN	I-NP
O	393	394	,	,	,	O
O	395	401	namely	namely	RB	B-ADVP
O	401	402	,	,	,	O
O	403	406	Bcl	Bcl	NN	B-NP
O	406	407	-	-	HYPH	O
O	407	408	2	2	CD	B-NP
O	408	409	.	.	.	O

O	410	413	The	The	DT	B-NP
O	414	425	alternative	alternative	JJ	I-NP
O	426	434	splicing	splicing	NN	I-NP
O	435	437	of	of	IN	B-PP
O	438	441	Brn	Brn	NN	B-NP
O	441	442	-	-	HYPH	B-NP
O	442	444	3a	3a	NN	I-NP
O	445	449	mRNA	mRNA	NN	I-NP
O	450	458	produces	produce	VBZ	B-VP
O	459	462	two	two	CD	B-NP
O	463	472	molecular	molecular	JJ	I-NP
O	473	478	forms	form	NNS	I-NP
O	478	479	:	:	:	O
O	480	481	a	a	DT	B-ADVP
O	482	488	longer	longer	RBR	I-ADVP
O	488	489	,	,	,	O
O	490	493	Bcl	Bcl	NN	B-NP
O	493	494	-	-	HYPH	B-NP
O	494	495	2	2	CD	I-NP
O	496	511	transactivating	transactivate	VBG	I-NP
O	512	516	form	form	NN	I-NP
O	516	517	,	,	,	O
O	518	521	and	and	CC	O
O	522	523	a	a	DT	B-NP
O	524	531	shorter	short	JJR	I-NP
O	532	540	inactive	inactive	JJ	I-NP
O	541	545	form	form	NN	I-NP
O	545	546	,	,	,	O
O	547	554	lacking	lack	VBG	B-VP
O	555	557	84	84	CD	B-NP
O	558	560	AA	AA	NN	I-NP
O	561	563	in	in	IN	B-PP
O	564	567	the	the	DT	B-NP
O	568	581	aminoterminus	aminoterminus	NN	I-NP
O	581	582	.	.	.	O

O	583	585	In	In	IN	B-PP
B-Cell	586	594	neuronal	neuronal	JJ	B-NP
I-Cell	595	600	cells	cell	NNS	I-NP
O	600	601	,	,	,	O
O	602	611	following	follow	VBG	B-PP
O	612	615	Brn	Brn	NN	B-NP
O	615	616	-	-	HYPH	I-NP
O	616	618	3a	3a	NN	I-NP
O	619	623	gene	gene	NN	I-NP
O	624	636	transfection	transfection	NN	I-NP
O	637	640	and	and	CC	O
O	641	656	superexpression	superexpression	NN	B-NP
O	656	657	,	,	,	O
O	658	660	an	an	DT	B-NP
O	661	669	increase	increase	NN	I-NP
O	670	672	of	of	IN	B-PP
O	673	675	30	30	CD	B-NP
O	676	680	fold	fold	RB	I-NP
O	681	683	of	of	IN	B-PP
O	684	687	the	the	DT	B-NP
O	688	691	Bcl	Bcl	NN	I-NP
O	691	692	-	-	HYPH	O
O	692	693	2	2	CD	B-NP
O	694	701	protein	protein	NN	I-NP
O	702	708	occurs	occur	VBZ	B-VP
O	708	709	,	,	,	O
O	710	717	leading	lead	VBG	B-VP
O	718	720	to	to	TO	B-PP
O	721	730	apoptosis	apoptosis	NN	B-NP
O	731	741	protection	protection	NN	I-NP
O	741	742	.	.	.	O

O	743	750	However	However	RB	B-ADVP
O	750	751	,	,	,	O
O	752	758	recent	recent	JJ	B-NP
O	759	764	works	work	NNS	I-NP
O	765	776	demonstrate	demonstrate	VBP	B-VP
O	777	781	that	that	IN	B-SBAR
O	782	785	Brn	Brn	NN	B-NP
O	785	786	-	-	HYPH	O
O	786	788	3a	3a	NN	B-NP
O	789	799	expression	expression	NN	I-NP
O	800	802	is	be	VBZ	B-VP
O	803	806	not	not	RB	O
O	807	817	restricted	restricted	JJ	B-ADJP
O	818	820	to	to	TO	B-PP
B-Cell	821	829	neuronal	neuronal	JJ	B-NP
I-Cell	830	835	cells	cell	NNS	I-NP
O	835	836	,	,	,	O
O	837	839	as	as	IN	B-SBAR
O	840	843	its	its	PRP$	B-NP
O	844	852	activity	activity	NN	I-NP
O	853	856	was	be	VBD	B-VP
O	857	865	detected	detect	VBN	I-VP
O	866	870	also	also	RB	B-ADVP
O	871	873	in	in	IN	B-PP
B-Cell	874	880	cancer	cancer	NN	B-NP
I-Cell	881	886	cells	cell	NNS	I-NP
O	887	889	of	of	IN	B-PP
O	890	893	non	non	AFX	B-NP
O	893	894	-	-	HYPH	I-NP
B-Cell	894	902	neuronal	neuronal	JJ	I-NP
O	903	909	nature	nature	NN	I-NP
O	909	910	.	.	.	O

O	911	918	Looking	Look	VBG	B-VP
O	919	922	for	for	IN	B-PP
O	923	933	mechanisms	mechanism	NNS	B-NP
O	934	941	linking	link	VBG	B-VP
O	942	945	Brn	Brn	NN	B-NP
O	945	946	-	-	HYPH	B-NP
O	946	948	3a	3a	NN	I-NP
O	949	951	to	to	TO	B-PP
O	952	966	carcinogenesis	carcinogenesis	NN	B-NP
O	966	967	,	,	,	O
O	968	970	we	we	PRP	B-NP
O	971	978	discuss	discuss	VBP	B-VP
O	979	982	the	the	DT	B-NP
O	983	987	role	role	NN	I-NP
O	988	990	of	of	IN	B-PP
O	991	995	this	this	DT	B-NP
O	996	1009	transcription	transcription	NN	I-NP
O	1010	1016	factor	factor	NN	I-NP
O	1017	1019	in	in	IN	B-PP
O	1020	1031	influencing	influence	VBG	B-VP
O	1032	1035	Bcl	Bcl	NN	B-NP
O	1035	1036	-	-	HYPH	B-NP
O	1036	1037	2	2	CD	I-NP
O	1037	1038	/	/	SYM	I-NP
O	1038	1041	p53	p53	NN	I-NP
O	1042	1052	antagonism	antagonism	NN	I-NP
O	1053	1056	and	and	CC	I-NP
O	1057	1060	Bcl	Bcl	NN	I-NP
O	1060	1061	-	-	HYPH	B-NP
O	1061	1062	2	2	CD	I-NP
O	1062	1063	/	/	SYM	I-NP
O	1063	1067	VEGF	VEGF	NN	I-NP
O	1068	1077	induction	induction	NN	I-NP
O	1078	1080	of	of	IN	B-PP
B-Cancer	1081	1086	tumor	tumor	NN	B-NP
O	1087	1099	angiogenesis	angiogenesis	NN	I-NP
O	1099	1100	,	,	,	O
O	1101	1111	concluding	conclude	VBG	B-VP
O	1112	1116	this	this	DT	B-NP
O	1117	1123	review	review	NN	I-NP
O	1124	1128	with	with	IN	B-PP
O	1129	1130	a	a	DT	B-NP
O	1131	1139	proposal	proposal	NN	I-NP
O	1140	1143	for	for	IN	B-PP
O	1144	1147	the	the	DT	B-NP
O	1148	1157	oncogenic	oncogenic	JJ	I-NP
O	1158	1164	nature	nature	NN	I-NP
O	1165	1167	of	of	IN	B-PP
O	1168	1171	Brn	Brn	NN	B-NP
O	1171	1172	-	-	HYPH	B-NP
O	1172	1174	3a	3a	NN	I-NP
O	1174	1175	.	.	.	O

